Evaluation of Contact Lenses and Myopia.

ConditionPre-myopia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age8-10
SponsorCooperVision International Limited (CVIL)

About this trial

This study will evaluate the effect of dual focus contact lenses on Myopia prevention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male and female children aged between 8-10 years inclusive.

Cycloplegic SER from -0.25 (non-inclusive) to +0.75 D (inclusive) in both eyes.

Astigmatism ≤ -1.00D in both eyes.

Un-corrected visual acuity (UCVA) ≤ 0.1 LogMAR.

Disqualifiers

History of myopia control intervention (e.g., atropine, orthokeratology, soft myopia control contact lenses, red light therapy, etc. over more than 1 month)

Currently wears rigid gas permeable contact lenses, including orthokeratology lenses.

Current use of systemic or ocular or medications which may affect contact lens wear, tear film production, pupil size, accommodation or refractive state.

Ocular or systemic disease that contraindicates contact lens wear.

Trial design

Design model

Single group

Treatments tested in this trial

  • Test Lens - Dual Focus

    Device

    Dual-Focus Contact Lens

Treatment groups

110 Participants
are divided into 1 treatment group
Group A: Test LensExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Myopia onset (cycloplegic SER ≤ -0.50D) in either or both eyes at 2 years.

Time frame
Through study completion, 2 years.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

CooperVision International Limited (CVIL)

Lead sponsor

Shanghai Eye Disease Prevention and Treatment Center

Collaborator